We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Ciena
CIEN
$58.7B
| $33K | ﹤0.01% |
+1,304
| New | +$31.2K |
|
|
ACH
627
Accendra Health
ACH
$227M
| $33K | ﹤0.01% |
1,019
+38
| +4% | +$1.25K |
|
628
Valley National Bancorp
VLY
$8.16B
| $33K | ﹤0.01% |
+2,825
| New | +$33.1K |
|
|
LHCG
629
DELISTED
LHC Group LLC
LHCG
| $33K | ﹤0.01% |
485
+94
| +24% | +$5.61K |
|
|
MANT
630
DELISTED
Mantech International Corp
MANT
| $33K | ﹤0.01% |
808
+23
| +3% | +$867 |
|
|
BGG
631
DELISTED
Briggs & Stratton Corp.
BGG
| $33K | ﹤0.01% |
1,380
+63
| +5% | +$1.49K |
|
|
BRSS
632
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $33K | ﹤0.01% |
1,081
+212
| +24% | +$6.8K |
|
|
PX
633
DELISTED
Praxair Inc
PX
| $33K | ﹤0.01% |
250
| – | – |
|
|
ALOG
634
DELISTED
Analogic Corp
ALOG
| $33K | ﹤0.01% |
+459
| New | +$32.9K |
|
635
CACI
CACI
$11.4B
| $32K | ﹤0.01% |
253
-29
| -10% | -$3.52K |
|
636
InterDigital
IDCC
$8.51B
| $32K | ﹤0.01% |
417
+31
| +8% | +$2.6K |
|
637
NETGEAR
NTGR
$651M
| $32K | ﹤0.01% |
749
+184
| +33% | +$8.43K |
|
638
Plexus
PLXS
$7.38B
| $32K | ﹤0.01% |
604
-27
| -4% | -$1.43K |
|
639
Portland General Electric
POR
$5.76B
| $32K | ﹤0.01% |
+699
| New | +$32.2K |
|
640
United Natural Foods
UNFI
$2.93B
| $32K | ﹤0.01% |
882
+183
| +26% | +$7.35K |
|
|
SYKE
641
DELISTED
SYKES Enterprises Inc
SYKE
| $32K | ﹤0.01% |
965
-259
| -21% | -$8.2K |
|
|
HMSY
642
DELISTED
HMS Holdings Corp.
HMSY
| $32K | ﹤0.01% |
1,754
+176
| +11% | +$3.39K |
|
|
AXE
643
DELISTED
Anixter International Inc
AXE
| $32K | ﹤0.01% |
414
+18
| +5% | +$1.41K |
|
|
IPHS
644
DELISTED
Innophos Holdings, Inc.
IPHS
| $32K | ﹤0.01% |
726
+172
| +31% | +$7.72K |
|
|
CVG
645
DELISTED
Convergys
CVG
| $32K | ﹤0.01% |
1,341
+57
| +4% | +$1.33K |
|
646
DTE Energy
DTE
$29B
| $31K | ﹤0.01% |
340
-7,041
| -95% | -$638K |
|
647
Edison International
EIX
$26.3B
| $31K | ﹤0.01% |
399
-8,303
| -95% | -$665K |
|
648
Haemonetics
HAE
$3.84B
| $31K | ﹤0.01% |
+773
| New | +$31.7K |
|
649
KLA
KLAC
$252B
| $31K | ﹤0.01% |
3,390
-70,450
| -95% | -$703K |
|
650
ePlus
PLUS
$2.47B
| $31K | ﹤0.01% |
836
+160
| +24% | +$5.8K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.